Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.57 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | FAAH | O00519 | 2/20 | 0.52 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.50 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.48 |
| ▸ | RAD52 | P43351 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | ACHE | P22303 | 6/20 | 0.47 |
| ▸ | DGKA | P23743 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4248770 | 0.87 | NAAA (0.57) | NAAAEPHX1TSHRFAAHZDHHC7 | |
| SCHEMBL9513622 | 0.87 | TSHR (0.53) | NAAAEPHX1TSHRFAAHZDHHC7 | |
| SCHEMBL7195180 | 0.85 | NAAA (0.55) | NAAAEPHX1TSHRFAAHZDHHC7 | |
| SCHEMBL11783281 | 0.85 | NAAA (0.55) | NAAAEPHX1TSHRFAAHZDHHC7 | |
| SCHEMBL15796074 | 0.85 | NAAA (0.55) | NAAAEPHX1TSHRFAAHZDHHC7 | |
| SCHEMBL22091902 | 0.85 | NAAA (0.55) | NAAAEPHX1TSHRFAAHZDHHC7 | |
| SCHEMBL21811917 | 0.85 | NAAA (0.55) | NAAAEPHX1TSHRFAAHZDHHC7 | |
| SCHEMBL7133351 | 0.85 | NAAA (0.55) | NAAAEPHX1TSHRFAAHZDHHC7 | |
| SCHEMBL52465 | 0.85 | NAAA (0.55) | NAAAEPHX1TSHRFAAHZDHHC7 | |
| SCHEMBL4252024 | 0.84 | NAAA (0.54) | NAAAEPHX1TSHRFAAHZDHHC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8841454-B2 | Functionalized carbon nanostructures which are soluble in hydrocarbons and method for preparation | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2014-09-23 | — | — | US | disclosed |
| US-8435931-B2 | Reduced friction lubricating oils containing functionalized carbon nanomaterials | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2013-05-07 | — | — | US | disclosed |
| EP-2454352-A1 | REDUCED FRICTION LUBRICATING OILS CONTAINING FUNCTIONALIZED CARBON NANOMATERIALS | ExxonMobil Research and Engineering Company (US) | 2012-05-23 | — | — | EP | disclosed |
| US-20110015423-A1 | Functionalized Carbon Nanostructures Which are Soluble in Hydrocarbons and Method for Preparation | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2011-01-20 | — | — | US | disclosed |
| US-20110015106-A1 | Reduced Friction Lubricating Oils Containing Functionalized Carbon Nanomaterials | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2011-01-20 | — | — | US | disclosed |
| WO-2011009026-A1 | FUNCTIONALIZED CARBON NANOSTRUCTURES WHICH ARE SOLUBLE IN HYDROCARBONS AND METHOD FOR PREPARATION | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2011-01-20 | — | — | WO | disclosed |
| WO-2011009025-A1 | REDUCED FRICTION LUBRICATING OILS CONTAINING FUNCTIONALIZED CARBON NANOMATERIALS | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2011-01-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110015423-A1 | Functionalized Carbon Nanostructures Which are Soluble in Hydrocarbons and Method for Preparation | ALKBH3, HCCS, CCL11 | NAAA 884/4885EPHX1 298/4885TSHR 3669/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.